Eden Research plc (LON:EDEN – Get Free Report)’s stock price was up 2.8% during mid-day trading on Tuesday after an insider bought additional shares in the company. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares traded hands during trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,902.58).
Eden Research Price Performance
The firm has a market capitalization of £19.73 million, a price-to-earnings ratio of -200.00 and a beta of 0.92. The stock’s fifty day moving average price is GBX 3.88 and its two-hundred day moving average price is GBX 4.02. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.25.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Recommended Stories
- Five stocks we like better than Eden Research
- Russell 2000 Index, How Investors Use it For Profitable Trading
- What Does the Future Hold for Eli Lilly?
- Investing in the High PE Growth Stocks
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- Insider Buying Explained: What Investors Need to Know
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.